GeoVax discontinues COVID-19 vaccine to focus on mpox and cancer programs

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. MU
5. GOOGL
6. APGE
7. LCO
8. KR
9. MSTR
10. HOOD

Go back to GeoVax discontinues COVID-19 vaccine to focus on mpox and cancer programs
GeoVax Labs, Inc. (NASDAQ: GOVX) Delayed: 1.33 -0.01 (0.75%)
Previous Close $1.34    52 Week High $0.14 
Open $1.38    52 Week Low $0.05 
Day High $1.43    P/E N/A 
Day Low $1.33    EPS $-0.14 
Volume 331,538